List of Figures
Figure 1: Global Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 2: Global Ventilator Market, By Months, 2020 (In USD Millions)
Figure 3: Global Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 4: Global Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 5: Global Prevalence of Stroke, 2014-2017 (In Millions)
Figure 6: Global Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 7: Global Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 8: Global Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 9: Global Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 10: Global Financial Stimulus Package Provided By Government, By Countries, 2020
Figure 11: Global Number of Intensive Care Beds, 2020 (In Numbers)
Figure 12: Global Number of Confirmed COVID19 Deaths, June 2020 (In Per Million People)
Figure 13: Global Ventilator Market, By Mobility, 2019, 2025
Figure 14: Global Ventilator Market - By Intensive Care, By Value (USD Million), 2015-2025
Figure 15: Global Ventilator Market - By Portable, By Value (USD Million), 2015-2025
Figure 16: Global Ventilator Market, By Modes, 2019, 2025
Figure 17: Global Ventilator Market - By Pressure, By Value (USD Million), 2015-2025
Figure 18: Global Ventilator Market - By Volume, By Value (USD Million), 2015-2025
Figure 19: Global Ventilator Market - By Combined, By Value (USD Million), 2015-2025
Figure 20: Global Ventilator Market - By Others, By Value (USD Million), 2015-2025
Figure 21: Global Ventilator Market, By Interface, 2019, 2025
Figure 22: Global Ventilator Market - By Invasive, By Value (USD Million), 2015-2025
Figure 23: Global Ventilator Market - By Non Invasive, By Value (USD Million), 2015-2025
Figure 24: Global Ventilator Market, By End User, 2019, 2025
Figure 25: Global Ventilator Market - By Hospitals, By Value (USD Million), 2015-2025
Figure 26: Global Ventilator Market - By Ambulatory Surgical Centers, By Value (USD Million), 2015-2025
Figure 27: Global Ventilator Market - By Home Care, By Value (USD Million), 2015-2025
Figure 28: Global Ventilator Market - By Others, By Value (USD Million), 2015-2025
Figure 29: Global Ventilator Market, By Region, 2019, 2025
Figure 30: North America Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 31: North America Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 32: North America Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 33: North America Prevalence of Stroke, 2014-2017 (In Millions)
Figure 34: North America Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 35: North America Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 36: North America Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 37: North America Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 38: North America Number of Intensive Care Beds, 2020 (In Numbers)
Figure 39: North America Number of Confirmed COVID19 Deaths, June 2020 (In Per Million People)
Figure 40: North America Ventilator Market - By Mobility, By Value, 2015-2025 (USD Million)
Figure 41: North America Ventilator Market - By Modes, By Value, 2015-2025 (USD Million)
Figure 42: North America Ventilator Market - By Interface, By Value, 2015-2025 (USD Million)
Figure 43: North America Ventilator Market - By End User, By Value, 2015-2025 (USD Million)
Figure 44: Market Opportunity Chart of North America Ventilator Market - By Country, By Value, 2025
Figure 45: North America Ventilator Market, By Country, 2019, 2025
Figure 46: United States Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 47: United States Projected Need for Non-Invasive Ventilators (In 1000)
Figure 48: United States Projected Need for Invasive Ventilators (In 1000)
Figure 49: United States Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 50: United States Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 51: United States Prevalence of Stroke, 2014-2017 (In Millions)
Figure 52: United States Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 53: United States Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 54: United States Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 55: United States Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 56: United States Average Income and Expenditures of All Consumer Units, 2017, 2018 (In %)
Figure 57: United States Ventilator Market - By Mobility, By Value, 2015-2025 (USD Million)
Figure 58: United States Ventilator Market - By Modes, By Value, 2015-2025 (USD Million)
Figure 59: United States Ventilator Market - By Interface, By Value, 2015-2025 (USD Million)
Figure 60: United States Ventilator Market - By End User, By Value, 2015-2025 (USD Million)
Figure 61: Canada Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 62: Canada Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 63: Canada Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 64: Canada Prevalence of Stroke, 2014-2017 (In Millions)
Figure 65: Canada Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 66: Canada Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 67: Canada Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 68: Canada Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 69: Canada Average Income and Expenditures Per Household, 2017, 2018 (In %)
Figure 70: Canada Ventilator Market - By Mobility, By Value, 2015-2025 (USD Million)
Figure 71: Canada Ventilator Market - By Modes, By Value, 2015-2025 (USD Million)
Figure 72: Canada Ventilator Market - By Interface, By Value, 2015-2025 (USD Million)
Figure 73: Canada Ventilator Market - By End User, By Value, 2015-2025 (USD Million)
Figure 74: Europe Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 75: Europe Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 76: Europe Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Millions)
Figure 77: Europe Prevalence of Stroke, 2014-2017 (In Millions)
Figure 78: Europe Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 79: Europe Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 80: Europe Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 81: Europe Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 82: European Union Household Expenditure, By Consumption Purpose, 2018 (In %)
Figure 83: Europe Number of Intensive Care Beds, 2020 (In Numbers)
Figure 84: Europe Number of Confirmed COVID19 Deaths, June 2020 (In Per Million People)
Figure 85: Europe Ventilator Market - By Mobility, By Value, 2015-2025 (USD Million)
Figure 86: Europe Ventilator Market - By Modes, By Value, 2015-2025 (USD Million)
Figure 87: Europe Ventilator Market - By Interface, By Value, 2015-2025 (USD Million)
Figure 88: Europe Ventilator Market - By End User, By Value, 2015-2025 (USD Million)
Figure 89: Market Opportunity Chart of Europe Ventilator Market - By Country, By Value, 2025
Figure 90: Europe Ventilator Market, By Country, 2019, 2025
Figure 91: Germany Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 92: Germany Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 93: Germany Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 94: Germany Prevalence of Stroke, 2014-2017 (In Millions)
Figure 95: Germany Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 96: Germany Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 97: Germany Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 98: Germany Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 99: Germany Household Expenditure, By Consumption Purpose, 2018 (In %)
Figure 100: Germany Ventilator Market - By Mobility, By Value, 2015-2025 (USD Million)
Figure 101: Germany Ventilator Market - By Modes, By Value, 2015-2025 (USD Million)
Figure 102: Germany Ventilator Market - By Interface, By Value, 2015-2025 (USD Million)
Figure 103: Germany Ventilator Market - By End User, By Value, 2015-2025 (USD Million)
Figure 104: France Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 105: France Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 106: France Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 107: France Prevalence of Stroke, 2014-2017 (In Millions)
Figure 108: France Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 109: France Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 110: France Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 111: France Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 112: France Household Expenditure, By Consumption Purpose, 2018 (In %)
Figure 113: France Ventilator Market - By Mobility, By Value, 2015-2025 (USD Million)
Figure 114: France Ventilator Market - By Modes, By Value, 2015-2025 (USD Million)
Figure 115: France Ventilator Market - By Interface, By Value, 2015-2025 (USD Million)
Figure 116: France Ventilator Market - By End User, By Value, 2015-2025 (USD Million)
Figure 117: United Kingdom Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 118: United Kingdom Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 119: United Kingdom Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 120: United Kingdom Prevalence of Stroke, 2014-2017 (In Millions)
Figure 121: United Kingdom Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 122: United Kingdom Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 123: United Kingdom Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 124: United Kingdom Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 125: United Kingdom Household Expenditure, By Consumption Purpose, 2018 (In %)
Figure 126: United Kingdom Ventilator Market - By Mobility, By Value, 2015-2025 (USD Million)
Figure 127: United Kingdom Ventilator Market - By Modes, By Value, 2015-2025 (USD Million)
Figure 128: United Kingdom Ventilator Market - By Interface, By Value, 2015-2025 (USD Million)
Figure 129: United Kingdom Ventilator Market - By End User, By Value, 2015-2025 (USD Million)
Figure 130: Italy Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 131: Italy Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 132: Italy Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 133: Italy Prevalence of Stroke, 2014-2017 (In Millions)
Figure 134: Italy Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 135: Italy Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 136: Italy Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 137: Italy Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 138: Italy Household Expenditure, By Consumption Purpose, 2018 (In %)
Figure 139: Italy Ventilator Market - By Mobility, By Value, 2015-2025 (USD Million)
Figure 140: Italy Ventilator Market - By Modes, By Value, 2015-2025 (USD Million)
Figure 141: Italy Ventilator Market - By Interface, By Value, 2015-2025 (USD Million)
Figure 142: Italy Ventilator Market - By End User, By Value, 2015-2025 (USD Million)
Figure 143: Asia Pacific Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 144: Asia Pacific Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 145: Asia Pacific Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 146: Asia Pacific Prevalence of Stroke, 2014-2017 (In Millions)
Figure 147: Asia Pacific Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 148: Asia Pacific Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 149: Asia Pacific Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 150: Asia Pacific Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 151: Asia Pacific Number of Intensive Care Beds, 2020 (In Numbers)
Figure 152: Asia Pacific Number of Confirmed COVID19 Deaths, June 2020 (In Per Million People)
Figure 153: Asia Pacific Ventilator Market - By Mobility, By Value, 2015-2025 (USD Million)
Figure 154: Asia Pacific Ventilator Market - By Modes, By Value, 2015-2025 (USD Million)
Figure 155: Asia Pacific Ventilator Market - By Interface, By Value, 2015-2025 (USD Million)
Figure 156: Asia Pacific Ventilator Market - By End User, By Value, 2015-2025 (USD Million)
Figure 157: Market Opportunity Chart of Asia Pacific Ventilator Market - By Country, By Value, 2025
Figure 158: Asia Pacific Ventilator Market, By Country, 2019, 2025
Figure 159: China Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 160: China Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 161: China Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 162: China Prevalence of Stroke, 2014-2017 (In Millions)
Figure 163: China Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 164: China Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 165: China Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 166: China Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 167: China Ventilator Market - By Mobility, By Value, 2015-2025 (USD Million)
Figure 168: China Ventilator Market - By Modes, By Value, 2015-2025 (USD Million)
Figure 169: China Ventilator Market - By Interface, By Value, 2015-2025 (USD Million)
Figure 170: China Ventilator Market - By End User, By Value, 2015-2025 (USD Million)
Figure 171: Japan Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 172: Japan Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 173: Japan Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 174: Japan Prevalence of Stroke, 2014-2017 (In Millions)
Figure 175: Japan Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 176: Japan Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 177: Japan Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 178: Japan Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 179: Japan Ventilator Market - By Mobility, By Value, 2015-2025 (USD Million)
Figure 180: Japan Ventilator Market - By Modes, By Value, 2015-2025 (USD Million)
Figure 181: Japan Ventilator Market - By Interface, By Value, 2015-2025 (USD Million)
Figure 182: Japan Ventilator Market - By End User, By Value, 2015-2025 (USD Million)
Figure 183: India Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 184: India Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 185: India Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 186: India Prevalence of Stroke, 2014-2017 (In Millions)
Figure 187: India Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 188: India Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 189: India Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 190: India Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 191: India Ventilator Market - By Mobility, By Value, 2015-2025 (USD Million)
Figure 192: India Ventilator Market - By Modes, By Value, 2015-2025 (USD Million)
Figure 193: India Ventilator Market - By Interface, By Value, 2015-2025 (USD Million)
Figure 194: India Ventilator Market - By End User, By Value, 2015-2025 (USD Million)
Figure 195: South Korea Ventilator Market Size, By Value, 2015-2025 (USD Million)
Figure 196: South Korea Prevalence of Chronic Respiratory Diseases, 2014-2017 (In Millions)
Figure 197: South Korea Prevalence of Respiratory Infection and Tuberculosis, 2014-2017 (In Billions)
Figure 198: South Korea Prevalence of Stroke, 2014-2017 (In Millions)
Figure 199: South Korea Prevalence of Chronic Obstructive Pulmonary Disease, 2014-2017 (In Millions)
Figure 200: South Korea Prevalence of Interstitial Lung Disease and Pulmonary Sarcoidosis, 2014-2017 (In Millions)
Figure 201: South Korea Prevalence of Multiple Sclerosis, 2014-2017 (In Millions)
Figure 202: South Korea Prevalence of Tracheal, Bronchus and Lung Cancer, 2014-2017 (In Millions)
Figure 203: South Korea Ventilator Market - By Mobility, By Value, 2015-2025 (USD Million)
Figure 204: South Korea Ventilator Market - By Modes, By Value, 2015-2025 (USD Million)
Figure 205: South Korea Ventilator Market - By Interface, By Value, 2015-2025 (USD Million)
Figure 206: South Korea Ventilator Market - By End User, By Value, 2015-2025 (USD Million)
Figure 207: Market Attractiveness Chart of Global Ventilator Market - By Mobility, 2025
Figure 208: Market Attractiveness Chart of Global Ventilator Market - By Modes, 2025
Figure 209: Market Attractiveness Chart of Global Ventilator Market - By Interface, 2025
Figure 210: Market Attractiveness Chart of Global Ventilator Market - By End User, 2025
Figure 211: Market Attractiveness Chart of Global Ventilator Market - By Region, 2025
Figure 212: Market Share of Leading Global Ventilator Companies, 2019 (In %)
Figure 213: Philips Group Revenue, 2015-2019 (In USD Billion)
Figure 214: Philips Group Revenue, By Business Segment, 2018 (In %)
Figure 215: Philips Group Revenue, By Business Segment, 2019 (In %)
Figure 216: Philips Group Revenue, By Diagnosis & Treatment, 2019 (In %)
Figure 217: Philips Group Revenue, By Connected Care, 2019 (In %)
Figure 218: Philips Group Revenue, By Personal Health, 2019 (In %)
Figure 219: Philips Group Revenue, By Countries, 2018 (In %)
Figure 220: Philips Group Revenue, By Countries, 2019 (In %)
Figure 221: Philips Group Revenue, By Countries, 2018 (In %)
Figure 222: Philips Group Revenue, By Countries, 2019 (In %)
Figure 223: ResMed Revenue, 2015-2019 (In USD Billion)
Figure 224: ResMed Net Revenue, By Business Segment, 2018 (In %)
Figure 225: ResMed Net Revenue, By Business Segment, 2019 (In %)
Figure 226: ResMed Net Revenue, By Region, 2018 (In %)
Figure 227: ResMed Net Revenue, By Region, 2019 (In %)
Figure 228: Medtronic Revenue, 2015-2019 (In USD Billion)
Figure 229: Medtronic Net Sales, By Region, 2018 (In %)
Figure 230: Medtronic Net Sales, By Region, 2019 (In %)
Figure 231: Medtronic Net Sales, By Business Segment, By Region, 2018 (In USD Million)
Figure 232: Medtronic Net Sales, By Business Segment, 2018 (In %)
Figure 233: Medtronic Net Sales, By Business Segment, 2019 (In %)
Figure 234: Becton, Dickinson and Company Revenue, 2015-2019 (In USD Billion)
Figure 235: Becton, Dickinson and Company Net Sales, By Business Segment, 2018 (In %)
Figure 236: Becton, Dickinson and Company Net Sales, By Business Segment, 2019 (In %)
Figure 237: Becton, Dickinson and Company Net Sales, By Geographical Region, 2018 (In %)
Figure 238: Becton, Dickinson and Company Net Sales, By Geographical Region, 2019 (In %)
Figure 239: Getinge Revenue, 2015-2019 (In USD Billion)
Figure 240: Getinge Net Sales, By Business Segment, 2018 (In %)
Figure 241: Getinge Net Sales, By Business Segment, 2019 (In %)
Figure 242: Getinge Net Sales, By Geographical Region, 2018 (In %)
Figure 243: Getinge Net Sales, By Geographical Region, 2019 (In %)
Figure 244: Drager Revenue, 2015-2019 (In USD Billion)
Figure 245: Drager Net Sales, By Business Segment, 2018 (In %)
Figure 246: Drager Net Sales, By Business Segment, 2019 (In %)
Figure 247: Drager Net Sales, By Geographical Region, 2018 (In %)
Figure 248: Drager Net Sales, By Geographical Region, 2019 (In %)
Figure 249: Smiths Group Revenue, 2015-2019 (In USD Billion)
Figure 250: Smiths Group Net Sales, By Market, 2018 (In %)
Figure 251: Smiths Group Net Sales, By Market, 2019 (In %)
Figure 252: Smiths Group Net Sales, By Business Division, 2018 (In %)
Figure 253: Smiths Group Net Sales, By Business Division, 2019 (In %)
Figure 254: Smiths Group Net Sales, By Regions, 2017 (In %)
Figure 255: Smiths Group Net Sales, By Regions, 2018 (In %)
Figure 256: GE Revenue, 2015-2019 (In USD Billion)
Figure 257: GE Net Sales, By Business Segment, 2018 (In %)
Figure 258: GE Net Sales, By Business Segment, 2019 (In %)
Figure 259: GE Net Sales, By Geographical Region, 2018 (In %)
Figure 260: GE Net Sales, By Geographical Region, 2019 (In %)
Figure 261: Fisher & Paykel Revenue, 2015-2019 (In USD Million)
Figure 262: Fisher & Paykel Net Sales, By Business Segment, 2018 (In %)
Figure 263: Fisher & Paykel Net Sales, By Business Segment, 2019 (In %)
Figure 264: Fisher & Paykel Net Sales, By Geographical Region, 2018 (In %)
Figure 265: Fisher & Paykel Net Sales, By Geographical Region, 2019 (In %)
